146,549 Danaher Corporation $DHR Shares Bought by Norris Perne & French LLP MI

Norris Perne & French LLP MI boosted its stake in shares of Danaher Corporation (NYSE:DHR) by 122.8% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 265,854 shares of the conglomerate’s stock after purchasing an additional 146,549 shares during the period. Danaher makes up approximately 2.6% of Norris Perne & French LLP MI’s portfolio, making the stock its 6th biggest holding. Norris Perne & French LLP MI’s holdings in Danaher were worth $58,900,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Signaturefd LLC boosted its position in Danaher by 29.8% in the 3rd quarter. Signaturefd LLC now owns 10,728 shares of the conglomerate’s stock worth $2,377,000 after purchasing an additional 2,464 shares in the last quarter. BG Investment Services LLC purchased a new position in shares of Danaher during the 3rd quarter valued at approximately $770,000. Simplicity Wealth LLC increased its holdings in shares of Danaher by 36.5% during the 3rd quarter. Simplicity Wealth LLC now owns 1,532 shares of the conglomerate’s stock valued at $339,000 after purchasing an additional 410 shares in the last quarter. Evergreen Capital Management LLC lifted its stake in shares of Danaher by 1.3% in the 3rd quarter. Evergreen Capital Management LLC now owns 12,037 shares of the conglomerate’s stock valued at $2,672,000 after purchasing an additional 158 shares during the period. Finally, Blodgett Wealth Advisors LLC acquired a new position in shares of Danaher in the 3rd quarter valued at $219,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

DHR has been the topic of several analyst reports. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $240.00 price target on shares of Danaher in a research report on Wednesday, July 22nd. Evercore reiterated an “outperform” rating and issued a $230.00 price objective on shares of Danaher in a research report on Monday, July 6th. Wall Street Zen lowered shares of Danaher from a “buy” rating to a “hold” rating in a research note on Sunday, October 18th. JPMorgan Chase & Co. increased their target price on shares of Danaher from $250.00 to $270.00 and gave the stock an “overweight” rating in a research note on Thursday. Finally, Morgan Stanley raised their target price on Danaher from $220.00 to $240.00 and gave the company an “overweight” rating in a research report on Monday, October 12th. One analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $242.91.

Key Stories Impacting Danaher

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: Danaher reported third-quarter adjusted earnings of $2.11 per share, above the $1.92 analyst consensus, while revenue reached approximately $6.55 billion. Revenue increased 8.3% year over year, and management raised its full-year 2026 adjusted EPS outlook. Danaher 3Q Net Up Sharply as Company Boosts 2026 Adjusted EPS View
• Positive Sentiment: Analysts raised their valuation targets following the results. TD Cowen and JPMorgan lifted targets to $270, Goldman Sachs raised its target to $275, Stifel increased its target to $260, and Robert W. Baird raised its target to $254. The firms maintained bullish ratings, including Buy, Overweight and Outperform. Danaher Analysts Raise Their Forecasts Following Better-Than-Expected Q3 Earnings
• Positive Sentiment: Management highlighted margin strength, improved execution and an increased focus on innovation and artificial intelligence, factors analysts viewed as supporting a better longer-term outlook. Danaher Earnings Call Highlights Margin Strength, AI Push
• Neutral Sentiment: Despite the earnings beat and higher targets, shares declined in the immediate post-results reaction, suggesting investors may have already priced in much of the improvement. A recent valuation comparison also frames DHR as a stock for investors weighing quality and growth against its relatively elevated valuation. Danaher Q3 Recap: Decent Results, Still A Hold
• Negative Sentiment: Danaher’s new CEO emphasized the need for better execution and innovation. TD Cowen cited tariff pressure and a cautious 2027 outlook, creating uncertainty beyond the raised 2026 guidance and helping explain why the stock did not fully respond to the strong quarterly report. Danaher Posts First Earnings Under New CEO

Danaher Trading Up 0.3%

Shares of DHR stock opened at $230.36 on Friday. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.63 and a quick ratio of 1.25. The company has a market cap of $162.07 billion, a price-to-earnings ratio of 37.70, a PEG ratio of 2.88 and a beta of 0.76. The stock has a 50 day simple moving average of $216.32 and a 200-day simple moving average of $197.35. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80.

Danaher (NYSE:DHR) last released its quarterly earnings results on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.92 by $0.19. Danaher had a net margin of 16.91% and a return on equity of 11.17%. The firm had revenue of $6.55 billion for the quarter, compared to analysts’ expectations of $6.56 billion. During the same quarter last year, the company earned $1.89 EPS. The firm’s revenue for the quarter was up 8.3% compared to the same quarter last year. On average, equities research analysts expect that Danaher Corporation will post 8.59 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be given a dividend of $0.40 per share. The ex-dividend date is Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a yield of 0.7%. Danaher’s dividend payout ratio is currently 26.19%.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.